Renaissance Technologies »

Vaneck Vectors Pharmaceutical etf shares owned by Renaissance Technologies

Quarter-by-quarter ownership of Vaneck Vectors Pharmaceutical etf (PPH) shares owned by Renaissance Technologies from 13F filings

Historical chart of Renaissance Technologies investment in Vaneck Vectors Pharmaceutical etf

Tip: Access up to 7 years of quarterly data

All positions including Vaneck Vectors Pharmaceutical etf held by Renaissance Technologies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaneck Vectors Pharmaceutical etf by Renaissance Technologies

Quarter filed Position value Share count Share price at filing
2023-09-30 $735k 9.2k 79.89
2023-06-30 $362k 4.6k 78.70
2023-03-31 $551k 7.1k 77.61
2019-03-31 $291k 4.8k 60.62
2018-12-31 $219k 4.0k 54.75

More positions owned by Renaissance Technologies

Novo-nordisk A S Adr (NVO)
Apple (AAPL)
Palantir Technologies Cl A (PLTR)
Verisign (VRSN)
Berkshire Hathaway Inc Del Cl A (BRK.A)
Airbnb Com Cl A (ABNB)
Vertex Pharmaceuticals Incorporated (VRTX)
NVIDIA Corporation (NVDA)
Netflix (NFLX)
United Therapeutics Corporation (UTHR)
Hershey Company (HSY)
Gilead Sciences (GILD)
Franco-Nevada Corporation (FNV)
Horizon Therapeutics Pub L SHS
Atlassian Corporation Cl A (TEAM)

View all positions for Renaissance Technologies

Top funds holding Vaneck Vectors Pharmaceutical etf

Goldman Sachs Group
Bank of America Corporation
Healthcare Of Ontario Pension Plan Trust Fund
Avalon Trust
Jpmorgan Chase & Co
Miller Investment Management
Prime Capital Investment Advisors
Bnp Paribas Arbitrage, Snc
Independent Advisor Alliance
Phoenix Holdings
Citadel Advisors
Avestar Capital
Gladstone Institutional Advisory
Hrt Financial
Twelve Points Wealth Management

View all funds holding Vaneck Vectors Pharmaceutical etf